MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by WHITE, T. D.
Right arrow Articles by KEEN, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by WHITE, T. D.
Right arrow Articles by KEEN, P.

Molecular Pharmacology, Vol 7, 40-45, Copyright © 1971 by the American Society for Pharmacology and Experimental Therapeutics

Effects of Inhibitors of (Na+ + K+)-Dependent Adenosine Triphosphatase on the Uptake of Norepinephrine by Synaptosomes

T. D. WHITE 1 and P. KEEN 1

1 Department of Pharmacology, Medical School, University of Bristol, Bristol BS8 1TD, England

The effects of various (Na+ + K+)-dependent adenosine triphosphatase inhibitors on synaptosomal adenosine triphosphatase activity and norepinephrine uptake were examined under similar conditions. Ouabain (1 mM) and oligomycin (10 µg/ml) inhibited both synaptosomal adenosine triphosphatase activity and norepinephrine uptake. However, strophanthidin (1 mM) and lower concentrations of ouabain (0.1 and 0.01 mM) inhibited adenosine triphosphatase activity to the same extent as 1 mM ouabain but did not depress the uptake of norepinephrine by synaptosomes. Thus, in these circumstances, the capacity of synaptosomes to accumulate norepinephrine is not correlated with their (Na+ + K+)-dependent adenosine triphosphatase activity. It also appears that ouabain can inhibit norepinephrine uptake by a mechanism which does not involve (Na+ + K+)-dependent adenosine triphosphatase.

Note:
ACKNOWLEDGMENTS We would like to thank Dr. B. T. Pickering for the use of a liquid scintillation counter, obtained through a grant from the Royal Society.

Submitted on September 3, 1970







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1971 by the American Society for Pharmacology and Experimental Therapeutics